Masaomi Ikeda
- Urology top 5%
- Urological Disorders and Treatments 14
-
- Renal cell carcinoma treatment 8
- Prostate Cancer Treatment and Research 5
- Prostate Cancer Diagnosis and Treatment 4
-
- Bladder and Urothelial Cancer Treatments 41
- Urinary and Genital Oncology Studies 34
-
- Cancer Genomics and Diagnostics 4
-
- Infectious Disease Case Reports and Treatments 6
- Co-authors
- Masatsugu IwamuraKazumasa MatsumotoTetsuo FujitaKen‐ichi TabataKazushige HayakawaShiro BabaTakefumi SatohHideyasu Tsumura
- Journals
- Journal of Clinical Oncology (2 papers)International Journal of Molecular Sciences (3 papers)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- Japan
In The Last Decade
Masaomi Ikeda
61 papers receiving 455 citations
Peers
Comparison fields: 5 of 61
- Urology 63
- Pulmonary and Respiratory Medicine 179
- Surgery 197
- Oncology 103
- Cancer Research 56
Countries citing papers authored by Masaomi Ikeda
This map shows the geographic impact of Masaomi Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaomi Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaomi Ikeda more than expected).
Fields of papers citing papers by Masaomi Ikeda
This network shows the impact of papers produced by Masaomi Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaomi Ikeda. The network helps show where Masaomi Ikeda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masaomi Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 0 | |
| 4 | 2020 | 7 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 4 | |
| 7 | 2018 | 6 | |
| 8 | 2018 | 6 | |
| 9 | 2015 | 10 | |
| 10 | 2015 | 8 | |
| 11 | 2014 | 15 | |
| 12 | 2014 | 9 | |
| 13 | 2013 | 14 | |
| 14 | 2013 | 14 | |
| 15 | 2013 | 1 | |
| 16 | 2012 | 19 | |
| 17 | 2011 | 9 | |
| 18 | 2008 | 1 | |
| 19 | 2007 | 1 | |
| 20 | Long-term administration of carmofur as a post-operative adjuvant chemotherapy for cervical adenocarcinoma | 1994 | 3 |
About Masaomi Ikeda
Masaomi Ikeda is a scholar working on Urology, Surgery and Pulmonary and Respiratory Medicine, having authored 65 papers that have together received 468 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (41 papers), Urinary and Genital Oncology Studies (34 papers), Urological Disorders and Treatments (14 papers), Renal cell carcinoma treatment (8 papers), Infectious Disease Case Reports and Treatments (6 papers), Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Urology (63 citations), Pulmonary and Respiratory Medicine (179 citations) and Surgery (197 citations). Masaomi Ikeda has collaborated with scholars based in Japan. Frequent co-authors include Masatsugu Iwamura, Kazumasa Matsumoto, Tetsuo Fujita, Ken‐ichi Tabata, Kazushige Hayakawa, Shiro Baba, Takefumi Satoh, Hideyasu Tsumura, Yuichi Sato and Daisuke Matsuda. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.